Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
/in Breast Cancer, Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2022-06-17 / Pharm Res 2022 Aug;39(8):1851-1866Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial)
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2022-06-16 / BMJ Open 2022 Jun;12(6):e060431Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2022-06-03 / Cancer Immunol Res 2022 Jun;10(6):728-744Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2022-04-28 / J Cancer Res Clin Oncol 2023 Apr;149(4):1425-1441Wilms‘ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory acute leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2022-03-10 / Ther Apher Dial 2022 Jun;26(3):537-547A comprehensive update to Dendritic Cell therapy for glioma: a systematic review and meta-analysis
/in Dendritic Cells, Glioblastoma, International Publications /von 2022-03-08 / Expert Rev Vaccines 2022 Apr;21(4):513-531Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2022-02-16 / Genes Immun 2022 Feb;Wilms‘ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory malignant lymphoma
/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2022-02-15 / Leuk Lymphoma 2022 Jul;63(7):1733-1737Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis
/in Dendritic Cells, Glioblastoma, International Publications /von 2022-02-04 / Curr Oncol 2022 Feb;29(2):881-891
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution